I spoke with Veronica Elsea, who has been blind since birth, about her experiences using diabetes technology as a blind person. We also discuss how her organization, The Accessible Insulin Pump Task Force, is collaborating with the industry to make diabetes tech more accessible for the visually impaired community.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Accessible Insulin Task Force Info

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

MARD (Mean Absolute Relative Difference) is often linked to continuous glucose monitor accuracy, but did you know there’s no universal standard for how companies measure it? In this episode, Tim Street from Diabettech dives into the lack of regulation in CGM clinical trials, revealing how manufacturers might manipulate MARD to appear more accurate.

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Follow Tim's Blog: Welcome to the Wild, Wild West: the CGM head-to-head study

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

CamAPS FX is the latest FDA cleared automated insulin delivery system for ages 2 and up, including during pregnancy. This app connects with a CGM and insulin pump to automate insulin delivery, simplifying diabetes management. Used in 17 European countries and expanding to New Zealand and Canada, CamAPS FX was developed by Dr. Roman Hovorka after 20 years of research at Cambridge University. Discover Dr. Hovorka's story and the impact of CamAPS FX in this episode.

Fill out T1D Exchange Registry (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

From longer wear times and more tubeless pump options to fully closed loop automated insulin systems, the future of insulin pumps looks bright. David Ahn and I dive into the innovations we’ll see in pump technology and what it all means.

Find a Doctor on ZocDoc (today's sponsor)

T1D Exchange Registry Sign up (US only)

Join our Newsletter | Diabetech Community Discord

Support Diabetech on Patreon

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook

Follow David Ahn here: Instagram | Tik Tok | X

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.

CeQur Simplicity is an innovative insulin patch designed to function like traditional insulin injections. This device is applied directly to the user's body, delivering 2 units of insulin with each click through its cannula. It is intended for meal coverage and correction doses, complementing long-acting insulin. I had the opportunity to speak with CeQur's CEO to learn more about the device's functionality, its current user base, and future developments.

T1D Exchange Registry Sign up (US only)

Read the InPen ADA Abstraction

Join our Newsletter | Diabetech Community Discord

Join Patreon for Exclusive Content

Follow my other pages: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.

Users are reporting they are unable to re-download the Dexcom G7 app outside their country. This is due to geofencing built into the smartphone app blocking users from downloading their home-country G7 app while abroad. If you plan to travel outside your country, here's what you should know and how to prepare if you use Dexcom G7.

T1D Exchange Registry Sign up (US residents only)

Join our Newsletter | Diabetech Community Discord

Join Patreon for Exclusive Content

Follow my other pages: Instagram | Tik Tok | YouTube | Facebook

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.

The UK's NICE guidelines represent the first time a country has made hybrid closed-loop widely available to its citizens through national healthcare. The groundbreaking guidelines instruct access to be granted to people with type 1 diabetes who fit a broad criteria over the next five years. How does health insurance work where you live? Comment on the Youtube episode (link below)!

T1D Exchange Registry Sign up (US residents only)

Join our Newsletter | Diabetech Community Discord

Join Patreon for Exclusive Content

Learn about the UK's NICE Guidelines

Follow my other pages: Instagram | Tik Tok | YouTube | Facebook

Send us Feedback & Join the Newsletter

Read

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.

I list off the tech I'm most excited about from the ADA's Scientific Sessions. I cover cgms like the Libre 3 Plus that now works with pumps and the latest Dexcom G7 upgrades. I get into pumps from the Omnipod iPhone app, the CeQur insulin patch, and the Luna overnight AID insulin pump. And I get into updates from the Vertex stem cell therapy findings that could lead to a cure for type 1 diabetes.

Find a Doctor on ZocDoc (today's sponsor)

T1D Exchange Registry Sign up (US residents only)

Join our Newsletter | Diabetech Community Discord

Join Patreon for Exclusive Content

Follow my other pages: Instagram | Tik Tok | YouTube | Facebook

More Videos from ADA:

Interview with Dexcom: https://youtu.be/FTjeMorMY30

Twiist Demo: https://youtu.be/FXaK77aFcV8

Send us Feedback & Join the Newsletter

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.